Literature DB >> 24729773

Statins and liver injury.

Manish Thapar1, Mark W Russo2, Herbert L Bonkovsky2.   

Abstract

Entities:  

Year:  2013        PMID： 24729773      PMCID： PMC3983981     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  16 in total

1.  Autoimmune hepatitis triggered by statins.

Authors:  Vamsee Alla; Joseph Abraham; Junaid Siddiqui; Dimple Raina; George Y Wu; Naga P Chalasani; Herbert L Bonkovsky
Journal:  J Clin Gastroenterol       Date:  2006-09       Impact factor: 3.062

2.  Statins are associated with a reduced risk of gastric cancer: a population-based case-control study.

Authors:  Hui-Fen Chiu; Shu-Chen Ho; Chih-Ching Chang; Trong-Neng Wu; Chun-Yuh Yang
Journal:  Am J Gastroenterol       Date:  2011-08-16       Impact factor: 10.864

3.  Statin-induced cholestatic hepatitis: confirmed on rechallenge.

Authors:  Sam Kerzner; Nenita Irabagon; Charles Berkelhammer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

4.  Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.

Authors:  Stephen A Harrison; Lorenzo Rossaro; Ke-Qin Hu; Keyur Patel; Hans Tillmann; Sandeep Dhaliwal; Dawn M Torres; Kenneth Koury; Venkata S Goteti; Stephanie Noviello; Clifford A Brass; Janice K Albrecht; John G McHutchison; Mark S Sulkowski
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.

Authors:  Timothy J Davern; Naga Chalasani; Robert J Fontana; Paul H Hayashi; Petr Protiva; David E Kleiner; Ronald E Engle; Hanh Nguyen; Suzanne U Emerson; Robert H Purcell; Hans L Tillmann; Jiezhun Gu; Jose Serrano; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2011-08-16       Impact factor: 22.682

6.  Statins and primary liver cancer: a meta-analysis of observational studies.

Authors:  Danitza Pradelli; Davide Soranna; Lorenza Scotti; Antonella Zambon; Alberico Catapano; Giuseppe Mancia; Carlo La Vecchia; Giovanni Corrao
Journal:  Eur J Cancer Prev       Date:  2013-05       Impact factor: 2.497

7.  Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  James H Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R Medoff; Rene Belder
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

Review 8.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Authors:  Jonathan A Tobert
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

9.  Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case-control study from Taiwan.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Hsueh-Chou Lai; Chih-Hsin Muo; Fung-Chang Sung
Journal:  Libyan J Med       Date:  2012-08-09       Impact factor: 1.657

Review 10.  Statins and colorectal cancer.

Authors:  Paul Lochhead; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-12       Impact factor: 11.382
View more
  10 in total

1.  Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.

Authors:  Zhiqiang Li; Yeun-Po Chiang; Mulin He; Ke Zhang; Jiao Zheng; Weihua Wu; Jiajia Cai; Yong Chen; Guangzhi Chen; Yunqin Chen; Jibin Dong; Tilla S Worgall; Xian-Cheng Jiang
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-02-02       Impact factor: 4.698

Review 2.  Treatment of Dyslipidemia in Common Liver Diseases.

Authors:  Elizabeth K Speliotes; Maya Balakrishnan; Lawrence S Friedman; Kathleen E Corey
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-21       Impact factor: 11.382

Review 3.  Statin-induced Liver Injury Patterns: A Clinical Review.

Authors:  Leon D Averbukh; Alla Turshudzhyan; David C Wu; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2022-01-10

4.  Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats.

Authors:  Mostafa Shahrezaee; Ahmad Oryan; Farshid Bastami; Sepanta Hosseinpour; Mohammad Hossein Shahrezaee; Amir Kamali
Journal:  Endocrine       Date:  2018-01-25       Impact factor: 3.633

Review 5.  Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.

Authors:  Seema Patel
Journal:  World J Microbiol Biotechnol       Date:  2016-04-02       Impact factor: 3.312

6.  Optimal duration for continuation of statin therapy in bacteremic patients.

Authors:  Ajinkya M Pawar; Kerry L LaPlante; Tristan T Timbrook; Aisling R Caffrey
Journal:  Ther Adv Infect Dis       Date:  2018-05-17

7.  The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.

Authors:  Cezary Chojnacki; Aleksandra Błońska; Jan Chojnacki
Journal:  Biomed Res Int       Date:  2017-05-29       Impact factor: 3.411

8.  Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy.

Authors:  Mezgebu Legesse Habte; Daniel Seifu Melka; Maria Degef; M K C Menon; Helen Yifter; Teka Obsa Feyisa
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-18       Impact factor: 3.168

9.  Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial.

Authors:  Paul B Watkins; Rachel J Church; Jie Li; Volker Knappertz
Journal:  Clin Pharmacol Ther       Date:  2020-11-21       Impact factor: 6.875

10.  Comparison of pleiotropic effects of statins vs fibrates on laboratory parameters in patients with dyslipidemia: A retrospective cohort study.

Authors:  Satoshi Takeuchi; Yasuo Takahashi; Satoshi Asai
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.